iiinova — where your digital self keeps evolving

Describe your patient in plain language and get open, enrolling cancer trials with the reason each one fits. Free for oncologists, funded by the NCI.

100

Mednet @themednet.bsky.social · 09/10/2026

"Many trials do not complete accrual, or accrue very slowly." — Lajos Pusztai, MD, DPhil, Chair, Breast Cancer Committee at SWOG Cancer Research Network

100

TrialMatch is a better way to find cancer trials, helping physicians quickly match their patients to enrolling clinical trials. Stop by to see it in action and chat with the team. 📍 Mednet Booth | SWOG Fall 2026 | Chicago, IL 📅 October 8–9

Describe your patient in plain language and get open, enrolling cancer trials with the reason each one fits. Free for oncologists, funded by the NCI.

100

We're live at the SWOG Fall 2026 Meeting in Chicago! 🎉 Nadine Housri, MD, Elizabeth Henry, MD, and Sam Laber are at the Mednet Booth running live TrialMatch demos.

100

Describe your patient in plain language and get open, enrolling cancer trials with the reason each one fits. Free for oncologists, funded by the NCI.

100

We're live at the SWOG Fall 2026 Meeting in Chicago! 🎉 Nadine Housri, MD, Elizabeth Henry, MD, and Sam Laber are at the Mednet Booth running live TrialMatch demos.

100

Describe your patient in plain language and get open, enrolling cancer trials with the reason each one fits. Free for oncologists, funded by the NCI.

100

We're live at the SWOG Fall 2026 Meeting in Chicago! 🎉 Nadine Housri, MD, Elizabeth Henry, MD, and Sam Laber are at the Mednet Booth running live TrialMatch demos.

100

Mednet TrialMatch Demo - Nadine Housri

Want a dedicated slot? Book time with us here: calendly.com/nhousri-medn... See you in Chicago! #SWOG #Oncology #ClinicalTrials #TrialMatch #Mednet

calendly.com

000

Mednet TrialMatch Demo - Nadine Housri

Stop by to meet: Nadine Housri, MD, Co-founder & Chief Medical Officer Elizabeth Henry, MD, Senior Medical Director for Oncology We'd love to show you a live demo, hear about your trial workflow, and talk about how we can support your practice.

calendly.com

100

Mednet @themednet.bsky.social · 29/09/2026

Heading to the SWOG Fall 2026 Meeting in Chicago? Come see us! The Mednet team will be at the TrialMatch Demo Booth from October 8–9, showing how TrialMatch helps oncologists connect their patients with the right clinical trials.

100

The American Society for Radiation Oncology (ASTRO) Annual Meeting 2026 Late-Breaking Abstract Session has concluded. Experts are now answering questions on Mednet. Head to the Q&A → gqr.sh/grB2 #ASTRO26 #RadOnc #LateBreaking #CancerResearch #MedEd

000

Mednet @themednet.bsky.social · 28/09/2026

The Plenary Session at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2026 has ended. Experts are now answering questions on Mednet. Head to the Q&A → gqr.sh/QpfP #ASTRO26 #RadOnc #ClinicalTrials #CancerResearch #MedEd

010

Mednet @themednet.bsky.social · 27/09/2026

The Clinical Trials Session at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2026 has wrapped up. Experts are now answering questions on Mednet. Head to the Q&A → gqr.sh/85HM #ASTRO26 #RadOnc #ClinicalTrials #CancerResearch #MedEd

011

Mednet @themednet.bsky.social · 23/09/2026

The American Society for Radiation Oncology (ASTRO) Annual Meeting 2026 is almost here – and the conversations won’t stop at the session. They’ll continue on Mednet. Join in at gqr.sh/QcgX

000

Mednet @themednet.bsky.social · 26/06/2026

They discuss how Mednet got its start, how the platform enables knowledge sharing among oncologists through online discussions and clinical insights, and what the future holds for patient communication in an AI-driven era.

100

Mednet @themednet.bsky.social · 26/06/2026

Dr. Nadine Housri, co-founder and Chief Medical Officer of Mednet, sat down with ASTRO President Dr. Neha Vapiwala for Episode 12 of ASTRO's Member Spotlight series.

100

Mednet @themednet.bsky.social · 10/06/2026

Here's what's new: ◉ Physician Community: A smarter search and more intuitive layout. Ask an expert or share your clinical knowledge with just a few taps. ◉ Mednet AI: Our clinical assistant is now mobile. Get fast, reliable answers that combine published literature with real-world expertise.

100

Mednet @themednet.bsky.social · 10/06/2026

We just released a major new update to the Mednet mobile app, available on both iOS and Android.

200

Mednet @themednet.bsky.social · 04/06/2026

Our Co-founder, Dr. Nadine Housri, joined the Value Health Voices podcast to talk about why AI alone can't solve medicine's hardest questions — and how Mednet is filling that gap with real physician knowledge. 🎙️ Full episode → share.transistor.fm/s/5266e3c0

000

Mednet @themednet.bsky.social · 03/06/2026

A full few days at #ASCO2026 - attending @Liza Henry’s panel discussion, hosting a great dinner for fellowship PDs, and talking with partners. As always, oncologists are continuing the conversations on Mednet. Check it out at themednet.org/join/medical...

000

Mednet @themednet.bsky.social · 19/05/2026

Our NYC team took on the city with a 90-minute mob-themed scavenger hunt through the streets of New York. The gold medals were well-earned. Congrats to our winners! 🥇 #OurTeam #NYC #TeamBuilding

000

Mednet @themednet.bsky.social · 24/04/2026

Excited to see Nadine Housri, MD, speaking at the 6th Annual Virtual Wisconsin Primary CNS Malignancy Symposium today, April 24. Her talk: “From Evidence to Judgment: Building AI for Real-World Oncology Decisions.” #Oncology #AIinHealthcare #BrainTumors #MedEd

000

Mednet @themednet.bsky.social · 21/04/2026

It's been exciting to bring this next chapter of Mednet into the conference setting and connect with more than 200 attendees so far. We're open through the last day today and grateful to everyone who has visited us. #AIMW26 #AAIM #AcademicMedicine #MedicalEducation #GME #AIinMedicine

000

Mednet @themednet.bsky.social · 21/04/2026

A big milestone for Mednet: our first-ever booth as a company at AAIM Week. It's been exciting to meet people in person, introduce Mednet AI, and hear thoughtful feedback from the community. #AIMW26 #AAIM #AcademicMedicine #MedicalEducation #GME #AIinMedicine

100

Mednet @themednet.bsky.social · 13/03/2026

The AI is only as good as the knowledge behind it. Mednet AI is a clinical assistant built on a foundation ten years in the making — 40,000+ physicians and 3,400 academic experts. ➝ www.themednet.org?utm_source=b... #MednetAI #MedSky #AIinHealthcare

000

Mednet @themednet.bsky.social · 12/03/2026

"Game-changer compared to traditional LLMs." — Panicker Renni Robinson, MD, Cardiology Fellow That's what Mednet AI was built for. Evidence + real expert opinion, combined. Free for all US physicians. ➝ www.themednet.org?utm_source=b... #MednetAI #MedSky #AIinHealthcare

100

Mednet @themednet.bsky.social · 11/03/2026

Most clinical assistants answer: what does the research say? Mednet AI answers: what do experienced physicians actually do? There's a difference. ➝ www.themednet.org?utm_source=b... #MednetAI #MedSky #AIinHealthcare

000

Mednet @themednet.bsky.social · 10/03/2026

We've got big news!! Mednet AI is now live — a clinical assistant informed by 10 years of real-world conversations from 40,000+ physicians, combined with the best of medical research. Free for all US physicians. Ask us anything. ➝ tinyurl.com/2jdzf75x #MednetAI #AI #AIinHealthcare #ClinicalAI

020

Reposted by Mednet

Donald Thomas, MD @lupusencyclopedia.bsky.social · 10/08/2025

@themednet.bsky.social has a new search ability making it even easier to find answers from colleagues. If not answered in the past, ask a new question to get answers from experts you trust: blog.themednet.org/the-new-medn...

012

Mednet @themednet.bsky.social · 03/03/2026

New on IDSA - Paul Sax, MD interviews Patrick Passarelli, MD (Dartmouth-Hitchcock; ID editor @Mednet) on getting expert guidance beyond AI + what makes a great clinical question. www.idsociety.org/multimedia/p... #MedEd #InfectiousDiseases

000

In mCRPC patients who had an initial response to Pluvicto but progress within 12 months, where do you position PSMA radioligand retreatment relative to other next-line systemic options in your sequencing strategy? www.themednet.org/v2/programs/199/questions?mode=question&questionId=27604"

020

Link to relevant Q&A: What criteria are you using for retreatment with Pluvicto (Lu-177) in those who maintain a good performance status and appropriate lab work? www.themednet.org/v2/programs/199/questions?mode=question&questionId=20197"

100

The American Society for Radiation Oncology (ASTRO) #MRPTS26 plenary session on Radiopharmaceutical Retreatment (Plenary II) just concluded. Dr. Ana Kiess is answering questions now on theMednet. Head to the Q&A → www.themednet.org/v2/programs/199/questions?mode=question&questionId=20197

110

Link to relevant Q&A: Does the possibility of future Lu-177–PSMA therapy change your current threshold to offer earlier metastasis-directed RT in oligometastatic prostate cancer? www.themednet.org/v2/programs/199/questions?mode=question&questionId=27603

100

Link to relevant Q&A: Can you give Pluvicto with concurrent palliative EBRT? www.themednet.org/v2/programs/199/questions?mode=question&questionId=17105

100

The American Society for Radiation Oncology (ASTRO) #MRPTS26 plenary session on Clinical Outcomes among Patients Treated with Lu-PSMA-617 and EBRT for Oligometastatic Prostate Cancer just concluded. Dr. Neil K Taunk is answering questions now on theMednet.

100

Links to relevant Q&A: When selecting mCRPC patients for Pluvicto, which baseline variables do you find most useful or predictive of potential hematologic toxicity? - www.themednet.org/v2/programs/199/questions?mode=question&questionId=27602

000

Links to relevant Q&A: Do you modify dosing and monitoring of Lu-177–PSMA therapy for patients with prior large-field RT involving substantial active marrow compared with patients who only had focal bone SBRT? - www.themednet.org/v2/programs/199/questions?mode=question&questionId=27601

100

The American Society for Radiation Oncology (ASTRO) #MRPTS26 plenary session on Hematologic Toxicity Outcomes of Lu-PSMA-617 in Patients Previously Treated with EBRT for Oligometastatic Disease just concluded. Drs. Neil K Taunk & Krishnan R Patel are answering questions now on theMednet.

100

Links to relevant Q&A: How do you sequence Pluvicto vs docetaxel in a fit, chemotherapy-naïve patient with high-volume PSMA-avid mCRPC progressing on an ARPI? - www.themednet.org/v2/programs/199/questions?mode=question&questionId=27599

A physician-only Q&A platform for expert answers to real world clinical questions

theMednet

000

Links to relevant Q&A: For patients starting Pluvicto, do you have patients stop their ARPI? - www.themednet.org/v2/programs/199/questions?mode=question&questionId=26213

A physician-only Q&A platform for expert answers to real world clinical questions

theMednet

100

ASTRO plenary session on Safety and Efficacy of Lu-177 PSMA-617 Versus Established Therapies in mCRPC: Pooled Evidence from Randomized Phase II/III Trials just concluded. Dr. John Nikitas is answering questions now on theMednet. Head to the Q&A → www.themednet.org/v2/programs/199/questions